Legacy Pharma Invest LP — Form D
Legacy Pharma Invest LP of TORONTO, A6, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-10-24. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-10-24
- Form: D
- Accession: 0001998028-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-495554
Issuer
- Name: Legacy Pharma Invest LP
- CIK: 0001998028
- Entity type: Limited Partnership
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2023
- Address: 135 YORKVILLE AVENUE, FLOOR 9, TORONTO, A6, M5R 0C7
- Phone: 416-925-6609
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| James Albrecht | Director | TORONTO, A6 |
| Andrew Lapham | Director | TORONTO, A6 |
| James Albrecht | Executive Officer | TORONTO, A6 |
| Andrew Lapham | Executive Officer | TORONTO, A6 |
| NA Legacy Pharma Invest GP Inc. | Promoter | TORONTO, A6 |
More